Boldenon 300 mg Cygnus

Boldenon 300 mg Cygnus is a high-potency 300 mg/mL Boldenone Undecylenate certified analytical reference standard supplied in 10 mL multidose vials exclusively for licensed analytical, forensic, and academic institutions. Each batch is verified to ≥99.5% purity using orthogonal techniques (HPLC, GC-MS, NMR, FTIR) and includes a comprehensive Certificate of Analysis with raw data. Intended solely for instrument calibration, method validation, anti-doping control, and residue analysis. Not for human or veterinary administration.

Physical and Chemical Properties

• Concentration: 300 mg/mL Boldenone Undecylenate
• Volume: 10 mL per vial
• Appearance: Clear golden-yellow viscous oil
• Molecular Formula: C₃₀H₄₄O₃
• Molecular Weight: 452.67 g/mol
• CAS Number: 13103-34-9
• Vehicle: Refined grape seed oil with benzyl benzoate (≥25%) and benzyl alcohol

(139 words)

Boldenon 300 mg Cygnus — Clinical & Pharmaceutical Reference Guide

Introduction

Boldenon 300 mg Cygnus is a pharmaceutical-grade 300 mg/mL certified reference material of Boldenone Undecylenate specifically formulated for professional analytical and forensic laboratories. The elevated 300 mg/mL concentration reflects formulations increasingly encountered in contemporary clandestine markets, making this product an essential high-range standard for WADA-accredited anti-doping laboratories, national forensic services, and university research programs worldwide. Boldenon 300 mg Cygnus provides licensed professionals with an ultra-pure, fully characterized reference for accurate detection and quantification of boldenone and its metabolites in complex biological matrices.

Key Features & Scientific Relevance

• Pharmaceutical-grade purity ≥99.5% confirmed by multiple orthogonal methods
• 300 mg/mL concentration in 10 mL vials – ideal for extended calibration ranges and high-level QC samples
• Critical reference material in ISO/IEC 17025-accredited and GLP-compliant facilities
• Complete analytical data package supporting regulatory submissions and peer-reviewed publications
• Secure, compliance-focused distribution for Schedule III controlled substances

Product Specifications

• Product Reference: Boldenon 300 mg Cygnus
• Active Ingredient: Boldenone Undecylenate 300 mg/mL
• Presentation: 10 mL sterile glass vial with bromobutyl stopper and tamper-evident seal
• Excipients: Grape seed oil USP, benzyl benzoate ≥25%, benzyl alcohol 2%
• IUPAC Name: (17β)-3-Oxoandrosta-1,4-dien-17-yl undec-10-enoate
• Classification: Long-acting anabolic-androgenic steroid ester (Schedule III / international equivalent)

Applications & Usage

Boldenon 300 mg Cygnus 10 mL is restricted to regulated professional applications including:

• Validation of ultra-sensitive LC-MS/MS and GC-MS methods for high-concentration samples
• Preparation of extended-range matrix-matched calibrators and fortified controls
• Forensic confirmation of boldenone administration in human and animal matrices
• Research into ester hydrolysis kinetics and phase II metabolism at elevated doses
• Proficiency testing and external quality assurance programs

All handling requires documented chain-of-custody and controlled-substance licensing.

Purity & Analytical Testing

Every batch undergoes exhaustive verification:

• HPLC-UV/DAD: ≥99.5% assay with full impurity profiling
• GC-MS (TMS derivatization): Diagnostic ions m/z 206, 296, 410, 452
• Quantitative 1H/13C NMR: Internal standard calibration against NIST-traceable references
• FTIR: Confirmation of ester carbonyl (1730 cm⁻¹) and conjugated dienone (1655 cm⁻¹)

Full raw data and processed results are supplied with each authenticated vial.

Safety & Handling Guidelines

Boldenone Undecylenate is classified Repr. 1B and potential carcinogen. Mandatory controls:

• Minimum PPE: nitrile gloves, lab coat, safety goggles, fume hood
• Storage: 2–8 °C protected from light; do not freeze
• Double-locked controlled-substance storage with restricted access
• Disposal via licensed hazardous waste contractor only

Secure & Confidential Distribution for Institutions

Delivery to verified institutions occurs in unmarked, temperature-monitored compliance packaging via tracked courier. No chemical identifiers appear on exterior labels. Documentation includes:

• Batch-specific Certificate of Analysis
• Safety Data Sheet
• Controlled-substance declaration forms (where required)

Possession requires valid DEA Schedule III registration or equivalent international licensing.

Why Choose This Reference Material?

• Exact 300 mg/mL concentration matches current high-potency clandestine formulations
• Comprehensive analytical documentation suitable for publication and regulatory filings
• Exceptional batch-to-batch consistency essential for longitudinal studies
• Trusted globally by anti-doping agencies, forensic institutes, and academic laboratories

Legal & Safety Disclaimer

Boldenon 300 mg Cygnus is supplied exclusively as an analytical reference standard for licensed laboratories and accredited research institutions. It is NOT FOR HUMAN OR VETERINARY USE, NOT AVAILABLE FOR INDIVIDUAL PURCHASE, and NOT INTENDED for self-administration. Unauthorized possession or distribution violates controlled-substance laws in most jurisdictions. Recipients bear full legal responsibility for compliance with all applicable regulations.

FAQ Section

What is the active compound in Boldenon 300 mg Cygnus? Boldenone Undecylenate 300 mg/mL — a long-acting ester prodrug of boldenone.

Is Boldenon 300 mg Cygnus a controlled substance? Yes — Schedule III in the United States and equivalently regulated worldwide.

How is the 300 mg/mL concentration verified? Quantitative NMR (qNMR) and reverse-phase HPLC with internal standardization.

What are the recommended storage conditions? Refrigerate at 2–8 °C in the original sealed vial, protected from light. Stable ≥36 months.

Who is authorized to acquire this reference material? Only accredited analytical laboratories, forensic facilities, and university departments holding valid controlled-substance licenses.

Is a Certificate of Analysis provided? Yes — every vial includes a comprehensive CoA with full analytical raw data and spectra.